 13. Receiving medications that meet one of the following criteria and that cannot be discontinued at least 1 week prior to the start of treatment with LDK378 and for the duration of the ETP participation see Appendix 1: Tables 14-1, Table 14-2, Table 14-3, and Table 14-4: 